Cleared Traditional

K923682 - MODEL M1032A VUELINK INTERFACE PLUG-IN ...

K923682 is the FDA 510(k) clearance for MODEL M1032A VUELINK INTERFACE PLUG-IN ... by Hewlett-Packard Co.. It is a Class 2 Anesthesiology device (product code DQA) cleared through the Traditional 510(k) pathway after a 67-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1992
Decision
67d
Days
Class 2
Risk

K923682 is an FDA 510(k) clearance for the MODEL M1032A VUELINK INTERFACE PLUG-IN MODULE. Classified as Oximeter (product code DQA), Class II - Special Controls.

Submitted by Hewlett-Packard Co. (Germany, DE). The FDA issued a Cleared decision on September 28, 1992 after a review of 67 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2700 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Hewlett-Packard Co. devices

Submission Details

510(k) Number K923682 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 23, 1992
Decision Date September 28, 1992
Days to Decision 67 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
73d faster than avg
Panel avg: 140d · This submission: 67d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQA Oximeter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - DQA Oximeter

All 407
Devices cleared under the same product code (DQA) and FDA review panel - the closest regulatory comparables to K923682.
NOVAMETRIX MODEL 510
K924626 · Novametrix Medical Systems, Inc. · Dec 1993
9293/1 INTERFACE MODULE
K923418 · S & W Medico Teknik · Feb 1993
HEWLETT-PACKARD MODEL M1020A PULSE OXIMETER
K923343 · Hewlett-Packard Co. · Feb 1993
NOVAMETRIX MODEL 7100 COMB. END TIDAL CO2 & PUL OX
K920379 · Novametrix Medical Systems, Inc. · Jul 1992
MODEL 520A NOVAMETRIX PULSE OXIMETER
K913516 · Novametrix Medical Systems, Inc. · Nov 1991
SYSTEM ATHENA, TYPE 9266 SA02, MODIFICATION
K911761 · S & W Medico Teknik · Oct 1991